Hiring of a tumor genomic determination service, designed to establish alterations in solid tumors and identify molecularly guided therapies with potential benefits for the patient and the level of evidence supporting it according to universally recognized scales (ESCAT, NCCN). The service is planned to be carried out on 694 samples (164 solid tissue tests embedded in paraffin and 530 liquid biopsy tests).

LOT-0001
CONTRACTING OF A TUMOR GENOMIC DETERMINATION SERVICE IN PATIENTS WITH SOLID TUMORS FOR THE IMPLEMENTATION OF THE RESEARCH PROJECT “PRECISION MEDICINE PROGRAM. STUDY PRECISO”-.
Hiring of a tumor genomic determination service, designed to establish alterations in solid tumors and identify molecularly guided therapies with potential benefits for the patient and the level of evidence supporting it according to universally recognized scales (ESCAT, NCCN). The service is planned to be carried out on 694 samples (164 solid tissue tests embedded in paraffin and 530 liquid biopsy tests).